Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

Open Label, Non-controlled Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone in Patients With Hyperphosphatemia Receiving Dialysis

To measure lanthanum concentrations in bone in patients with hyperphosphatemia receiving dialysis

Inclusion Criteria:

• Patients undergoing dialysis or plan to start dialysis before the initial administration of the study medication

Exclusion Criteria:

• Patients with severe hypocalcemia (adjusted serum calcium level of <7.5 mg/dL)